Effectiveness of Human Papillomavirus Vaccine for Adolescent Girls in Preventing Cervical Cancer
DOI:
https://doi.org/10.53089/medula.v14i2.994Abstract
With high mortality rates worldwide, cervical cancer is a major threat to women's health. The World Health Organization (WHO) has set a global strategy for elimination through HPV vaccination. Indonesia has implemented the HPV Immunization Introduction Program, including its implementation in the School Children Immunization Month, aimed at grade 5 and 6 elementary schools. The prevalence of cervical lesions has been reduced by HPV vaccination, but screening and adapting to changing epidemiology remain challenging. The influence of socioeconomic factors on risk highlights the need for prevention strategies that address social disparities. Successful vaccination not only protects individuals but also contributes to overall public health. Therefore, it requires adaptation and collaboration across sectors to address cervical cancer globally.
References
World Health Organization. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva: World Health Organization; 2020.
World Health Organization. WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention, Second Edition. Geneva: World Health Organization; 2021.
Menteri Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/1930/2022 tentang Program Introduksi Imunisasi Human Papillomavirus Vaccine (HPV) Tahun 2022-2023. Jakarta: Menteri Kesehatan Republik Indonesia; 2022.
Tripathi A, Sahu U. An Overview of HPV: Causes, Symptoms, and Clinical Manifestations. Dalam: Khare P, Jain A, editor. Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies. Cambridge: Academic Press.
Sahu U, Khare P. Pathogenesis and Immune Response Against HPV Infection. Dalam: Khare P, Jain A, editor. Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies. Cambridge: Academic Press.
Evriarti P, Yasmon A. Patogenesis Human Papillomavirus (HPV) pada Kanker Serviks. Jurnal Biotek Medisiana Indonesia. 2019;8(1):23–32.
Van Doorslaer K, Chen Z, Bernard H, Chan P, Desalle R, Dillner J, Dkk. ICTV virus Taxonomy Profile: Papillomaviridae. Journal of General Virology. 2018;99(8):989–990.
Soheili M, Keyvani H, Soheili M, Nasseri S. Human Papilloma Virus: A Review Study of Epidemiology, Carcinogenesis, Diagnostic Methods, and Treatment of All HPV-Related Cancers. Med J Islam Repub Iran. 2021;35(65):1–16.
Noor R, Aryanti, Hartono P. Genotipe HPV dan Pola Infeksinya Terkait Jenis Histopatologi Kanker Leher Rahim. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2014;21(1):67-74.
Wierzbicka M, San Giorgi M, Dikkers F. Transmission and Clearance of Human Papillomavirus Infection in the Oral Cavity and its Role in Oropharyngeal Carcinoma – A Review. Reviews in Medical Virology. 2023;33(1).
Meites E, Gee J, Unger E. Human Papillomavirus. Dalam: Hall E, Wodi R, Hamborsky J, Morelli V, Schillie S, Dana P, editor. Centers for Disease Control and Prevention: Epidemiology and Prevention of Vaccine-Preventable Diseases, Fourteenth Edition. Washington, D.C. Public Health Foundation.
Dehlendorff C, Sparén, P, Baldur-Felskov B, Herweijer E, Arnheim-Dahlström L, Ploner A, Dkk. Effectiveness of Varying Number of Doses and Timing Between Doses of Quadrivalent HPV Vaccine Against Severe Cervical Lesions. Vaccine. 2018; 36(43):6373–6378.
Kavanagh K, Pollock KGJ, Potts A, Love J, Cushieri K, Cubie H, Dkk. Introduction and Sustained High Coverage of the HPV Bivalent Vaccine Leads to a Reduction in Prevalence of HPV 16/18 and Closely Related HPV Types. British Journal of Cancer. 2014;110: 2804–2811.
Kim J, Bell C, Sun M, Kliewer G, Xu L, McInerney M, Dkk. Effect of Human Papillomavirus Vaccination on Cervical Cancer Screening in Alberta. CMAJ. 2016; 188(12):281–288.
Brotherton, JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early Effect of the HPV Vaccination Programme on Cervical Abnormalities in Victoria, Australia: An Ecological Study. The Lancet. 2011; 377(9783):2085–2092.
Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Cummins E, Liu B, Dkk. Fall in Human Papillomavirus Prevalence Following a National Vaccination Program. J Infect Dis. 2012; 206(11):1645–1651.
Baldur-Felskov B, Dehlendorff C, Junge J, Munk C, Kjaer SK. Incidence of Cervical Lesions in Danish Women Before and After Implementation of a National HPV Vaccination Program. Cancer Causes & Control. 2014; 25(7):915–922.
Crowe E, Pandeya N, Brotherton JML, Dobson AJ, Kisely S, Lambert SB, Whiteman DC. Effectiveness of Quadrivalent Human Papillomavirus Vaccine for the Prevention of Cervical Abnormalities: Case-Control Study Nested Within a Population Based Screening Programme In Australia. BMJ. 2014; 348(1458):1–10.
Shiko Y, Konno R, Konishi H, Sauvaget C, Ohashi Y, Kakizoe T. Effectiveness of HPV Vaccination Against the Development of High-Grade Cervical Lesions in Young Japanese Women. BMC Infectious Disease. 2020;20(808):1–6.
Palmer TJ, Kavanagh K, Cuschieri K, Cameron R, Graham C, Wilson A, Dkk. Invasive Cervical Cancer Incidence Following Bivalent Human Papillomavirus Vaccination: A Population-Based Observational Study of Age at Immunization, Dose, and Deprivation. JNCI: Journal of the National Cancer Institute. 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
